David J. Wambeke

Insider Reports History

Entity
Individual
Location
301 Carlson Parkway, Suite 210, Minneapolis, Minnesota
Signature
/s/Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David J. Wambeke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Business Officer Voting Common Shares, no par value per share 527K $1.48M $2.80 Jun 1, 2024 Direct
DiaMedica Therapeutics Inc. Chief Business Officer Stock Option (right to buy) 130K Jun 1, 2024 Direct

Insider Reports Filed by David J. Wambeke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2024 1 $0 4 Jun 3, 2024 Chief Business Officer
DMAC DiaMedica Therapeutics Inc. Nov 16, 2023 1 $49.2K 4 Nov 16, 2023 Chief Business Officer
DMAC DiaMedica Therapeutics Inc. Jun 23, 2023 1 $150K 4 Jun 26, 2023 Chief Business Officer
DMAC DiaMedica Therapeutics Inc. Apr 10, 2023 2 $750K 4 Apr 11, 2023 Chief Business Officer
DMAC DiaMedica Therapeutics Inc. Apr 10, 2023 0 $0 3 Apr 11, 2023 Chief Business Officer